2T8-3E10細胞

ATCC Number： HB-8213?

生長狀態： 懸浮生長

運輸方式： 凍存運輸

是否是腫瘤細胞： 0

物種來源： 小鼠

數量： 大量

細胞形態： **樣

**類型： IgM

Designations: 2T8-3E10

2T8-3E10細胞Depositors: Dana Farber Cancer Inst.

Isotype: IgM

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: suspension

Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)

Morphology: lymphoblast

Source: Cell Type: hybridoma: B lymphocyte;

Cellular Products: 2T8-3E10細胞immunoglobulin; monoclonal antibody; against human T cell antigen (Ti1b antigen) expressed only on the CT8III cytotoxic T lymphocyte clone

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Tumorigenic: Yes

Comments: Animals were immunized with CT8III cells.

Spleen cells were fused with NS-1 myeloma cells.

The antibody does not react with human thymocytes or resting or activated peripheral T cells.

Propagation: 2T8-3E10細胞ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 64%; NCTC 109 medium, 10%; L-glutamine, 2%; sodium pyruvate, 1%; hypoxanthine-thymidine, 1%; oxaloacetic acid and insulin, 1%; horse serum, 10%; fetal bovine serum, 10%

Subculturing: Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.

References: 3546: Schlossman SF, et al. 2T8-3E10細胞Monoclonal antibodies that recognize human T cells. US Patent 4,550,086 dated Oct 29 1985